Advertisement

Studies on Competition and Antitrust Issues in the Pharmaceutical Industry

  • Ann-Kathrin Lehnhausen

Part of the BestMasters book series (BEST)

Table of contents

  1. Front Matter
    Pages I-XIV
  2. Ann-Kathrin Lehnhausen
    Pages 1-3
  3. Ann-Kathrin Lehnhausen
    Pages 5-21
  4. Ann-Kathrin Lehnhausen
    Pages 23-57
  5. Ann-Kathrin Lehnhausen
    Pages 59-68
  6. Ann-Kathrin Lehnhausen
    Pages 69-70
  7. Back Matter
    Pages 71-85

About this book

Introduction

This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug’s patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies. 

Contents
• Overview of Antitrust and Competition Issues
• Vertical Restraints under Parallel Trade
• Competitive Restraints under Reference Pricing
Target Groups
• Scholars and students of economics and business administration with a focus on pharmacoeconomics and competition law
• Executives and consultants in health insurance companies and regulatory institutions

About the Author
Ann-Kathrin Lehnhausen, M.Sc. in Business Administration and M.A. in Economics, worked at Justus-Liebig-University Giessen as teaching asssistant during her studies. After her graduation she started working as junior sales manager, responsible for API Exports, at a pharmaceutical company, where she combines her interest in economics with her interest in the pharmaceutical market.

Keywords

Pharmaceutical Industry Overview Parallel Trade and Vertical Restraints Competition Restraints under Reference Pricing Restraints against Generic Market Entry Pay for Delay Merger and Acquisition

Authors and affiliations

  • Ann-Kathrin Lehnhausen
    • 1
  1. 1.VWl I – Industrieökonomie, Wettbewerbspolitik- und RegulierungJL UniversitätGießenGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-658-16551-2
  • Copyright Information Springer Fachmedien Wiesbaden GmbH 2017
  • Publisher Name Springer Gabler, Wiesbaden
  • eBook Packages Business and Management
  • Print ISBN 978-3-658-16550-5
  • Online ISBN 978-3-658-16551-2
  • Buy this book on publisher's site
Industry Sectors
Pharma
Automotive
Chemical Manufacturing
Biotechnology
Finance, Business & Banking
Electronics
Consumer Packaged Goods
Energy, Utilities & Environment
Engineering